Organisation: GlaxoSmithKline

Appellate court hands down guidance on induced infringement cases

28 June 2024

The US Federal Trade Commission is ramping up pressure on pharma patentees

02 May 2024

Meanwhile BioNTech and Moderna face off in the UK, and another mRNA spat settles

29 April 2024

The case is latest of many recent life sciences confidential information disputes

02 April 2024

The commission recently vowed to take action on alleged anticompetitive IP tactics

13 November 2023

Pathbreaking joint venture between academia and Big Pharma addresses university IP monetisation challenges

12 September 2023

The company’s distinctive dealmaking approach has produced many successes to date

28 July 2023

Lionel Bently K.C., Margaret ‘Meg’ Boulware, Dale Cendali and Brian Hinman are the four individuals selected for induction this year.

22 May 2023

The Supreme Court yesterday handed down one of the most anticipated patent decisions in decades

19 May 2023

The decision, leaving in place a polarising Federal Circuit decision, has significant implications for life sciences IP strategies

16 May 2023